In the tumor tissues of patients with primary non-small cell lung cancer, the positive expression rate of METTL3 is higher than that of normal tissues around the cancer, and the level of METTL3 is associated with the patient’s tumor size, depth of invasion, and lymph node metastasis14. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.